OncoSec Medical Incorporated

ONCSQOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$596

P/E Ratio—

52W High$0.0001

52W Low$0.00001

Avg Volume66K

Open$0.00

Beta9.82

Overview

OncoSec Medical Incorporated (ONCSQ) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

ONCSQ · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2023Report Date: Jan 31, 2023

EPS Actual

-$2.65

Est. -$28.90 · +90.8%

Revenue

—

Fiscal Period

Q1 FY2023

FY ends December

Report Date

Jan 31, 2023

After Market Close

▲ Beat EPS🔥 4-Quarter EPS Beat Streak

ONCSQ reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	Jun 17, 2026	—	—	—	—	—	—
◌ Q2 FY2026	Jun 17, 2026	-$6.75	—	—	—	—	—
◌ Q1 FY2026	Mar 30, 2026	—	—	—	—	—	—
◌ Q1 FY2026	Mar 25, 2026	-$8.90	—	—	—	—	—
◌ Q4 FY2024	Oct 25, 2024	—	—	—	—	—	—
◌ Q2 FY2024	Jun 12, 2024	—	—	—	—	—	—
◌ Q4 FY2023	Oct 27, 2023	-$17.17	—	—	—	—	—
◌ Q2 FY2023	Jun 15, 2023	-$16.98	—	—	—	—	—

Q2 FY2026

Jun 17, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 17, 2026

EPS Actual

—

EPS Est.

-$6.75

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 30, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 25, 2026

EPS Actual

—

EPS Est.

-$8.90

EPS Surpr.

—

Revenue

—

Q4 FY2024

Oct 25, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2024

Jun 12, 2024

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2023

Oct 27, 2023

EPS Actual

—

EPS Est.

-$17.17

EPS Surpr.

—

Revenue

—

Q2 FY2023

Jun 15, 2023

EPS Actual

—

EPS Est.

-$16.98

EPS Surpr.

—

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q2 FY2029	$-17.17	$-17.17	$-17.17	1
Q1 FY2029	$-16.98	$-16.98	$-16.98	1
Q4 FY2028	$-17.17	$-17.17	$-17.17	1
Q3 FY2028	$-16.98	$-16.98	$-16.98	1
Q2 FY2028	$-28.90	$-28.90	$-28.90	1
Q1 FY2028	$-107.77	$-107.77	$-107.77	1

Revenue Estimates

Period	Low	Consensus	High
Q2 FY2029	$0.0B	$0.0B	$0.0B
Q1 FY2029	$0.0B	$0.0B	$0.0B
Q4 FY2028	$0.0B	$0.0B	$0.0B
Q3 FY2028	$0.0B	$0.0B	$0.0B
Q2 FY2028	$0.0B	$0.0B	$0.0B
Q1 FY2028	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▲ Q1 FY2023	Jan 31, 2023	+90.8%	$0.21	$0.22	+2.80%
▲ Q4 FY2022	Oct 31, 2022	+95.8%	$0.96	$0.92	-3.45%
▲ Q3 FY2022	Jul 31, 2022	+0.6%	$1.58	$1.64	+3.80%
▲ Q2 FY2022	Apr 30, 2022	+0.8%	$1.87	$1.85	-1.07%

Q1 FY2023+2.80%

Report Date

Jan 31, 2023

EPS Beat/Miss

+90.8%

Price Before

$0.21

Price After

$0.22

Q4 FY2022-3.45%

Report Date

Oct 31, 2022

EPS Beat/Miss

+95.8%

Price Before

$0.96

Price After

$0.92

Q3 FY2022+3.80%

Report Date

Jul 31, 2022

EPS Beat/Miss

+0.6%

Price Before

$1.58

Price After

$1.64

Q2 FY2022-1.07%

Report Date

Apr 30, 2022

EPS Beat/Miss

+0.8%

Price Before

$1.87

Price After

$1.85

Avg Beat Reaction+0.52%

Beat Rate4 / 4 quarters

Largest Move+3.80% (Q3 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

OncoSec Medical Incorporated (ONCSQ) most recently reported earnings on January 31, 2023 for Q1 FY2023, posting EPS of $-2.65 — beating the analyst consensus of $-28.90 by +90.8%. ONCSQ has beaten EPS estimates for 4 consecutive quarters. The next ONCSQ earnings date is expected around September 1, 2026.

Each quarter, investors track ONCSQ earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ONCSQ revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

ONCSQ's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

ONCSQ earnings · 5 questions

OncoSec Medical Incorporated's next earnings report is expected around September 1, 2026. ONCSQ typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ONCSQ historically reports after market close (AMC).

ONCSQ earnings datewhen is ONCSQ earningsONCSQ next earnings datewhen does ONCSQ report earningsONCSQ earnings calendar

▸ Source: FMP · OncoSec Medical Incorporated SEC filings · US GAAP · OncoSec Medical Incorporated SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026